Allmed Medical Products Co., Ltd (002950.SZ)
CNY 8.87
(-0.11%)
CNY 8.87
(-0.11%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 146.31 Million CNY | 31.28% |
| 2022 | 111.44 Million CNY | -13.07% |
| 2021 | 128.2 Million CNY | 28.2% |
| 2020 | 100 Million CNY | -46.45% |
| 2019 | 186.74 Million CNY | -18.1% |
| 2018 | 228 Million CNY | 48.05% |
| 2017 | 154 Million CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 122.13 Million CNY | -14.96% |
| 2024 Q1 | 143.61 Million CNY | -1.84% |
| 2024 Q3 | 123.43 Million CNY | 1.06% |
| 2023 Q1 | 108.99 Million CNY | -2.2% |
| 2023 FY | 146.31 Million CNY | 31.28% |
| 2023 Q4 | 146.31 Million CNY | -25.2% |
| 2023 Q3 | 195.6 Million CNY | 25.48% |
| 2023 Q2 | 155.88 Million CNY | 43.02% |
| 2022 Q3 | 161.25 Million CNY | -1.89% |
| 2022 Q4 | 111.44 Million CNY | -30.89% |
| 2022 Q2 | 164.35 Million CNY | 30.73% |
| 2022 Q1 | 125.72 Million CNY | -1.93% |
| 2022 FY | 111.44 Million CNY | -13.07% |
| 2021 Q4 | 128.2 Million CNY | -46.52% |
| 2021 Q2 | 213.88 Million CNY | 113.89% |
| 2021 FY | 128.2 Million CNY | 28.2% |
| 2021 Q3 | 239.7 Million CNY | 12.07% |
| 2021 Q1 | 100 Million CNY | 0.0% |
| 2020 Q3 | - CNY | -100.0% |
| 2020 Q1 | 140.25 Million CNY | -24.89% |
| 2020 Q2 | 5.06 Million CNY | -96.39% |
| 2020 Q4 | 100 Million CNY | 0.0% |
| 2020 FY | 100 Million CNY | -46.45% |
| 2019 Q3 | 318 Million CNY | 10.42% |
| 2019 FY | 186.74 Million CNY | -18.1% |
| 2019 Q4 | 186.74 Million CNY | -41.28% |
| 2019 Q2 | 288 Million CNY | 26.32% |
| 2019 Q1 | 228 Million CNY | 0.0% |
| 2018 FY | 228 Million CNY | 48.05% |
| 2018 Q4 | 228 Million CNY | 28.09% |
| 2018 Q3 | 178 Million CNY | 0.0% |
| 2018 Q1 | - CNY | -100.0% |
| 2017 Q4 | 154 Million CNY | 0.0% |
| 2017 Q2 | 78 Million CNY | 0.0% |
| 2017 FY | 154 Million CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |